The Delhi High Court Monday came down heavily on the drug controller for not properly examining how BJP MP Gautam Gambhir procured huge quantity of Fabiflu, used for treating COVID-19 patients, and said the tendency of people to take advantage of a situation to appear as saviours has to be denounced. The high court said its confidence in the drug controller has shaken and rejected its status report filed in connection with its inquiry into procurement of the medicine by the cricketer-turned-politician Gambhir. The high court said everyone knows that the drug was in short supply and while Gambhir bought thousands of strips of the medicine, other people who needed it could not get it on that day.